Lantheus Holdings Inc (LNTH)

Lantheus Holdings Inc (LNTH) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.5B; returns 1 day -0.3%, 1 week +0.1%, 1 year +76.6%.

Lantheus Holdings, Inc. (LNTH) is a radiopharmaceutical-focused company that develops, manufactures, and commercializes diagnostic and therapeutic products for heart, cancer, and other diseases. Lantheus classifies its products into three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships.

Groups LNTH belongs to

• Healthcare
• Shrinking Share Count
• Buying Back Stock
• Life Sciences
• Oncology
• Health Diagnostics and Imaging
• Commercial Stage
• Precision Medicine
• Healthcare Technology
• Medical Devices
• Pharmaceuticals
• Biotechnology

LNTH financial model: income statement, cash flow and balance sheet